Insider · CIK 0001505998

GUINAN MARK

Reports to the SEC for 4 companies · BATESVILLE, IN

sec.gov

Transactions

Companies

Filings

CIK

0001505998

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-01-31	UpHealth, Inc.A Award	Director	AAward	+100K sh	—	—	160,606
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21.1K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−58.6K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21.6K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.D Disposition to Issuer	Director	DDisposition to Issuer	−3,673 sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45K sh	—	—	0
2022-12-16	UpHealth, Inc.A Award	Director	AAward	+60.6K sh	—	—	60,606
2022-10-26	Myovant Sciences Ltd.A Award	Director	AAward	+9,859 sh	—	—	9,859
2022-03-07	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−10.5K sh	$130.09	−$1.36M	98,981
2022-03-07	DGXQUEST DIAGNOSTICS INCA Award	Executive Vice President & CFO	AAward	+20.8K sh	$130.09	+$2.7M	109,456
2022-02-24	DGXQUEST DIAGNOSTICS INCA Award	Executive Vice President & CFO	AAward	+2,251 sh	—	—	88,676
2022-02-24	DGXQUEST DIAGNOSTICS INC · Non-Qualifed Stock Option (right to buy)A Award	Executive Vice President & CFO	AAward	+10.9K sh	—	—	10,932
2022-02-23	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−1,673 sh	$130.09	−$218K	87,119
2022-02-23	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−694 sh	$130.23	−$90.4K	86,425
2021-11-05	Myovant Sciences Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+21.1K sh	—	—	21,096
2021-03-09	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−6,403 sh	$115.42	−$739K	88,792
2021-03-09	DGXQUEST DIAGNOSTICS INCA Award	Executive Vice President & CFO	AAward	+17.3K sh	$115.42	+$2M	95,195
2021-02-24	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−541 sh	$121.19	−$65.6K	77,873
2021-02-23	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−830 sh	$121.15	−$101K	78,414
2021-02-17	DGXQUEST DIAGNOSTICS INC · Non-Qualifed Stock Option (right to buy)A Award	Executive Vice President & CFO	AAward	+31.8K sh	—	—	31,774
2021-02-17	DGXQUEST DIAGNOSTICS INCA Award	Executive Vice President & CFO	AAward	+5,665 sh	—	—	79,244
2020-12-24	DGXQUEST DIAGNOSTICS INCS Sale	Executive Vice President & CFO	SSale	−22.6K sh	$121.18	−$2.73M	73,579
2020-12-24	DGXQUEST DIAGNOSTICS INCS Sale	Executive Vice President & CFO	SSale	−59.2K sh	$120.06	−$7.11M	96,142
2020-12-24	DGXQUEST DIAGNOSTICS INCM Exercise/Conversion	Executive Vice President & CFO	MExercise/Conversion	+81.8K sh	$66.51	+$5.44M	155,335
2020-12-24	DGXQUEST DIAGNOSTICS INC · Non-Qualifed Stock Option (right to buy)M Exercise/Conversion	Executive Vice President & CFO	MExercise/Conversion	−81.8K sh	$66.51	−$5.44M	0
2020-09-15	Myovant Sciences Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+21.6K sh	—	—	21,603
2020-06-08	DGXQUEST DIAGNOSTICS INCS Sale	Executive Vice President & CFO	SSale	−18.2K sh	$117.65	−$2.15M	82,103
2020-06-08	DGXQUEST DIAGNOSTICS INCS Sale	Executive Vice President & CFO	SSale	−45.8K sh	$116.81	−$5.35M	100,349
2020-06-08	DGXQUEST DIAGNOSTICS INCM Exercise/Conversion	Executive Vice President & CFO	MExercise/Conversion	+72.6K sh	$71.17	+$5.17M	146,175
2020-06-08	DGXQUEST DIAGNOSTICS INCS Sale	Executive Vice President & CFO	SSale	−8,524 sh	$118.60	−$1.01M	73,579
2020-06-08	DGXQUEST DIAGNOSTICS INC · Non-Qualifed Stock Option (right to buy)M Exercise/Conversion	Executive Vice President & CFO	MExercise/Conversion	−72.6K sh	$71.17	−$5.17M	0
2020-03-10	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−3,870 sh	$106.46	−$412K	73,579
2020-03-10	DGXQUEST DIAGNOSTICS INCA Award	Executive Vice President & CFO	AAward	+7,693 sh	$106.46	+$819K	77,449
2020-02-26	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−1,195 sh	$112.90	−$135K	69,756
2020-02-25	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−565 sh	$113.34	−$64K	70,951
2020-02-24	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−653 sh	$112.17	−$73.2K	71,516
2020-02-18	DGXQUEST DIAGNOSTICS INC · Non-Qualifed Stock Option (right to buy)A Award	Executive Vice President & CFO	AAward	+40.1K sh	—	—	40,120
2020-02-18	DGXQUEST DIAGNOSTICS INCA Award	Executive Vice President & CFO	AAward	+6,152 sh	—	—	72,169
2019-08-23	Myovant Sciences Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+58.6K sh	—	—	58,608
2019-06-13	DGXQUEST DIAGNOSTICS INC · Stock Options (Right to Buy)M Exercise/Conversion	Executive Vice President & CFO	MExercise/Conversion	−73K sh	$52.16	−$3.81M	0
2019-06-13	DGXQUEST DIAGNOSTICS INCM Exercise/Conversion	Executive Vice President & CFO	MExercise/Conversion	+73K sh	$52.16	+$3.81M	139,022
2019-06-13	DGXQUEST DIAGNOSTICS INCS Sale	Executive Vice President & CFO	SSale	−73K sh	$100.00	−$7.3M	66,017
2019-03-01	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−5,288 sh	$86.86	−$459K	66,017
2019-03-01	DGXQUEST DIAGNOSTICS INCA Award	Executive Vice President & CFO	AAward	+10.7K sh	$86.86	+$933K	71,305
2019-02-26	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−1,556 sh	$87.84	−$137K	60,569
2019-02-25	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−660 sh	$88.24	−$58.2K	62,125
2019-02-22	DGXQUEST DIAGNOSTICS INCF Tax Payment	Executive Vice President & CFO	FTax Payment	−610 sh	$88.39	−$53.9K	62,785
2019-02-18	DGXQUEST DIAGNOSTICS INC · Non-Qualifed Stock Option (right to buy)A Award	Executive Vice President & CFO	AAward	+63.3K sh	—	—	63,259
2019-02-18	DGXQUEST DIAGNOSTICS INCA Award	Executive Vice President & CFO	AAward	+5,195 sh	—	—	63,395
2018-07-23	Myovant Sciences Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+45K sh	—	—	45,000

Recent filings

Accepted (ET)
Feb 24
GUINAN MARK0001062993-24-001879
SEC(opens sec.gov)
Mar 104
GUINAN MARK0001209191-23-017717
SEC(opens sec.gov)
Dec 194
GUINAN MARK0001062993-22-024180
SEC(opens sec.gov)
Oct 284
GUINAN MARK0001209191-22-054816
SEC(opens sec.gov)
Mar 94
GUINAN MARK0001022079-22-000058
SEC(opens sec.gov)
Feb 284
GUINAN MARK0001022079-22-000033
SEC(opens sec.gov)
Feb 254
GUINAN MARK0001022079-22-000017
SEC(opens sec.gov)
Nov 94
GUINAN MARK0001209191-21-063677
SEC(opens sec.gov)
Mar 114
GUINAN MARK0001022079-21-000054
SEC(opens sec.gov)
Feb 254
GUINAN MARK0001022079-21-000040
SEC(opens sec.gov)
Feb 194
GUINAN MARK0001022079-21-000019
SEC(opens sec.gov)

Companies

Address

1069 STATE ROUTE 46 EAST

BATESVILLE, IN, 47006